Noonan综合征患者PTPN11基因突变分析  

Mutation analysis of PTPN11 gene in Noonan syndrome

作　　者：杨涛[1] 孟岩[1] 施惠平[1] 赵时敏[2] 王刚[1] 黄尚志[1] 

机构地区：[1]中国医学科学院基础医学研究所、北京协和医学院基础学院医学遗传学系、WHO遗传病社区控制合作中心,北京100005 [2]中国医学科学院北京协和医院儿科

出　　处：《中华医学遗传学杂志》2010年第5期554-558,共5页Chinese Journal of Medical Genetics

基　　金：科技部“十五”国家科技攻关计划课题（2004BA720A04）;中国医学科学院基础医学研究所院长基金（2009PY17）;“十一五”国家科技支撑计划项目（2006BA105A08）;北京市科学技术委员会研发攻关类基金（D0906005040491）

摘　　要：目的 研究中国人Noonan综合征患者非受体型蛋白酪氨酸磷酸酯酶（protein-tyrosine phosphatase,nonreceptor-type 11,PTPN11）基因的突变.方法 收集遗传咨询门诊3例散发的Noonan综合征患者及其无症状父母,外周血提取基因组DNA,PCR产物直接测序法对患者PTPN11基因的全部15个编码区外显子及其邻接的内含子区域进行测序,检出突变后再对其父母的相应外显子区域进行测序,并通过限制性内切酶检测100名无亲缘关系的正常人相应碱基改变以排除多态性,利用网上ClustalW工具分析突变位点所在氨基酸在多个物种中的保守性.结果 在1例患者的第3外显子区域检出一杂合的c.181G＞A碱基取代,导致第61位的天冬氨酸改变为天冬酰胺（p.D61N）,在其无症状父母和100名正常个体中无此突变;该位点在多个物种中高度保守.另外2例患者PTPN11基因的编码区未检到突变.结论 p.D61N突变在文献中已有报道,本例患者为新生突变.本研究进一步肯定了 p.D61N为Noonan综合征的致病突变,基因诊断的结果验证了该患者的临床诊断.另外两例Noonan综合征患者可能由其他基因的突变所致,反映了该病的遗传异质性.Objective To investigate the mutations in protein tyrosine phosphatase, nonreceptor-type 11 （PTPN11）gene in patients with Noonan syndrome （NS）. Methods Three sporadic patients with NS were studied. Genomic DNAs were extracted from peripheral blood leukocytes. All 15 coding exons and their flanking intronic boundaries of the PTPN11 gene were amplified by polymerase chain reaction and followed by direct sequencing. DNAs from parents were sequenced in the corresponding region when the mutation was detected in their affected child. The identified mutation was screened in 100 healthy individuals for exclusion of polymorphism by restriction endonuclease digestion of the PCR products. Protein conservation analysis was performed among 10 species using an online ClustalW tool. Results Direct DNA sequence analysis identified a heterozygous 181G to A change in exon 3 of the PTPN11 gene in one patient,which resulted in the substitution of an aspartic acid residue by an asparagine at codon 61. The mutation was absent in his parents and 100 controls, and is located in a highly conserved amino acid site. No mutation in the coding region of PTPN11 gene was observed in the other two patients. Conclusion The p. D61N mutation was reported previously in Caucasians and is a de-novo mutation in this patient. Our study further confirmed that the p. D61N is a pathogenic mutation for NS and consistent with the clinical diagnosis.Additional genes may be involved in the other two patients with NS, indicating high genetic heterogeneity of this disease.

关 键 词：NOONAN综合征 PTPN11基因 基因突变 

分 类 号：R686[医药卫生—骨科学]